Cicero Diagnostics
Huntington Beach
About Cicero Diagnostics
Cicero Diagnostics is a women’s healthcare diagnostic company. It is dedicated to the advancement of clinical assays for understudied women’s diseases primarily in the area of infertility. Its current testing platforms, under the brand ReceptivaDx™ , include several biomarkers highly associated with inflammation on the uterine lining most often diagnosed as endometriosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Last round: Grant (Feb 2020)
- Website: cicerodx.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Women's
Social Profiles
Canonical: https://fsome.com/organization/cicero-diagnostics-142392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.